Effects of exogenous neuropeptide Y on automaticity of isolated Purkinje fibers and atrium

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 5, 1996, Pages 967-975

  Sosunov, Eugene A ^a   Anyukhovsky, Evgeny P ^a   Rosen, Michael R ^a  

^a Coll Phys/Surgs of Columbia Univ ^*  (United States)

Author keywords

Abnormal automaticity; Neuropeptide Y; Normal automaticity; Purkinje fibers; Sinus node

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y [18-36]; NORADRENALIN;

ANIMAL TISSUE; ARTICLE; DOG; FEMALE; GUINEA PIG; HEART AUTOMATICITY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART RIGHT ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PURKINJE FIBER; SINUS NODE; SINUS RHYTHM; SYMPATHETIC NERVE; VAGUS NERVE;

EID: 0029952193     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0090     Document Type: Article

References (35)

1. ALLEN JM, GOERSTRUP P, BJOERKMAN J-A, EK L, ABRAHAMSSON T, BLOOM SR, 1986. Studies on cardiac distribution and function of neuropeptide Y. Acta Physiol Scand 126: 405-411.
2. ALLEN JM, BIRCHAM PMM, EDWARDS AV, TATEMOTO K, BLOOM SR, 1983. Neuropeptide Y(NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Peptides 6: 247-253.
3. AWAD AJ, EINSTEIN R, POTTER E, RICHARDSON DP, 1991. The effects of neuropeptides Y on myocardial contractility and coronary blood flow. Br J Pharmacol 104: 195-201.
4. BALASUBRAMANIAM A, SHERIFF S, 1990. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes. J. Biol Chem 265: 14724-14727.
5. BALASUBRAMANIAM A, SHERIFF S, RIGEL DF, FISCHER JE, 1990. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides 11: 545-550.
6. BALASUBRAMANIAM A, GRUPP I, MATLIB MA, BENZA R, JACKSON RL, FISCHER JE, GRUPP G, 1988. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria. Regul Peptides 21: 289-299.
7. BRYANT SM, RYDER KO, HART G, 1991. Effects of neuropeptide Y on cell length and membrane currents in isolated guinea pig ventricular myocytes. Circ Res 69: 1106-1113.
8. CHANG F, YU H, COHEN IS, 1994. Actions of vasoactive intestinal peptide and neuropeptide Y on the pacemaker current in canine Purkinje fibers. Circ Res 74: 157-162.
9. 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ Res 67: 1535-1551.
10. EDVINSSON L, ERLINGE D, SUN XY, HEDNER T, 1994. Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists. Pharm Toxicol 74: 193-201.
11. EDVINSSON L, HAKANSON R, WAHLESTEDT C, UDDMAN R, 1987. Effects of neuropeptide Yon the cardiovascular system. Trends in Physiol Sci 8: 231-235.
12. ERTL G, BAUER B, BECKER H-H, ROSE G, 1993. Effects of neurotensin and neuropeptide Y on coronary circulation and myocardial function in dogs. Am J Physiol 264: H1062-H1068.
13. FRANCO-CERECEDA A, LUNDBERG JM, DAHLOEF C, 1985. Neuropeptide Y and sympathetic control of heart and coronary vascular tone. Acta Physiol Scand 124: 361-369.
14. GU J, POLAK JM, ALLEN JM, HUANG WM, SHEPPARD MN, TATEMOTO K, BLOOM SR, 1984. High concentrations of a novel peptide, neuropeptide Y in the innervation of mouse and rat heart. J Histochem Cytochem 32: 467-472.
15. HAAS M, CHENG B, RICHARDT G, LANG RE, SCHOMIG A, 1989. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea-pig heart. Naunyn-Schmiedeberg's Arch Pharmacol 339: 71-78.
16. LUNDBERG JM, MARTINSSON A, THEODORSSON-NORHEIM E, SVEDENHAG E, EKBLOM B, HJEMDAHL P, 1985. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 133: 30-36.
17. LUNDBERG JM, HUA X-Y, FRANCO-CERECEDA A, 1984. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol Scand 121: 325-332.
18. MCDERMOTT BJ, MILLAR BC, PIPER HM, 1993. Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc Res 27: 893-905.
19. MILLAR BC, WEIS T, PIPER HM, WEBER M, BORCHARD U, MCDERMOTT BJ, BALASUBRAMANIAM A, 1991. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes.Am J Physiol 261: H1727-H1733.
20. NETO FR, SPERELAKIS N, 1989. Analysis of the hyperpolarizing effect of catecholamines on canine cardiac Purkinje fibres. Br J Pharmacol 96: 591-598.
21. PERNOW JM, LUNDBERG JM, KAIJSER L, HJEMDAHL P, THEODORSSON-NORHEIM E, MARTINSSON A, PERNOW B, 1986. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6: 561-578.
22. PIPER HM, MILLAR BC, MCDERMOTT BJ, 1989. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte. Naunyn-Schmiedeberg's Arch Pharmacol 340: 333-337.
23. POTTER EK, 1988. Neuropeptide Y as an autonomie neurotransmitter. Phannacol Ther 37: 251-273.
24. RIGEL DF, 1988. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY CGRP, and NT. Am Physiol 255: H311-H317.
25. RIOUX F, BACHELARD H, MARTEL J-C, ST-PIERRE S, 1985. The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart. Peptides 7: 27-31.
26. ROSEN MR, HORDOF AJ, ILVENTO JP, DANILO JR P, 1977. Effects of adrenergic amines on electrophysiological properties and automaticity of neonatal and adult canine Purkinje fibers: evidence for α- and β-adrenergic actions. Circ Res 40: 390-400.
27. ROSEN MR, MERKER C, GELBLAND H, HOFFMAN BF, 1973. Effects of procaineamide on the electrophysiological properties the canine ventricular conducting system. J Pharmacol Exp Ther 185: 438-446.
28. SNEDECOR G, COCHRAN W, 1980. Statistical Methods. The Iowa State University Press, Ames, IA, USA.
29. STAJAERNE L, LUNDBERG JM, ASTRAND P, 1986. Neuropeptide Y - a cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mou se vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18: 151-166.
30. + current generates a "pacemaker" current at diastolic potentials in Purkinje myocytes. Circulation 90: 14.
31. WAHLESTEDT C, WOHLFART B, HAKANSON R, 1987. Effects of neuropeptide Y (NPY) on isolated guinea-pig heart. Acta Physiol Scand 129: 459-463.
32. WALKER P, GROUZMANN E, BURNIER M, WAEBER B, 1991. The role of neuropeptide Y in cardiovascular regulation. Trends in Physiol Sci 12: 111-115.
33. WARNER MR, LEVY M, 1989. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res 65: 1536-1546.
34. WHARTON J, GULBENKIAN S, 1989. Peptides in the mammalian cardiovascular system. Experientia 56: 292-316.
35. WILLIAMS RS, DUKES DF, LEFKOWITZ RJ, 1981. Subtype specificity of a-adrenergic receptors in rat heart. J Cardiovasc Pharmacol 3: 522-531.